Cargando…

DIFFERENCES IN CLINICAL CHARACTERISTICS, TREATMENT, AND OUTCOME OF PULMONARY EMBOLISM ACCORDING TO COVID-19 STATUS

Detalles Bibliográficos
Autores principales: KELTY, CATHERINE, LEACCHE, MARZIA, KNOX, MICHAEL, H PITCHER, JOSEPH, BERJAOUI, WAEL, M VANOTTEREN, GLENN, CUMMINGS, TREVOR, SHRESTHA, NABIN, L VANDYKE, ERIN, J MORRISON, JAMES, LOYAGA-RENDON, RENZO
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Chest Physicians. Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548725/
http://dx.doi.org/10.1016/j.chest.2022.08.1938
_version_ 1784805496119623680
author KELTY, CATHERINE
LEACCHE, MARZIA
KNOX, MICHAEL
H PITCHER, JOSEPH
BERJAOUI, WAEL
M VANOTTEREN, GLENN
CUMMINGS, TREVOR
SHRESTHA, NABIN
L VANDYKE, ERIN
J MORRISON, JAMES
LOYAGA-RENDON, RENZO
author_facet KELTY, CATHERINE
LEACCHE, MARZIA
KNOX, MICHAEL
H PITCHER, JOSEPH
BERJAOUI, WAEL
M VANOTTEREN, GLENN
CUMMINGS, TREVOR
SHRESTHA, NABIN
L VANDYKE, ERIN
J MORRISON, JAMES
LOYAGA-RENDON, RENZO
author_sort KELTY, CATHERINE
collection PubMed
description
format Online
Article
Text
id pubmed-9548725
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American College of Chest Physicians. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-95487252022-10-11 DIFFERENCES IN CLINICAL CHARACTERISTICS, TREATMENT, AND OUTCOME OF PULMONARY EMBOLISM ACCORDING TO COVID-19 STATUS KELTY, CATHERINE LEACCHE, MARZIA KNOX, MICHAEL H PITCHER, JOSEPH BERJAOUI, WAEL M VANOTTEREN, GLENN CUMMINGS, TREVOR SHRESTHA, NABIN L VANDYKE, ERIN J MORRISON, JAMES LOYAGA-RENDON, RENZO Chest Pulmonary Vascular Disease American College of Chest Physicians. Published by Elsevier Inc. 2022-10 2022-10-10 /pmc/articles/PMC9548725/ http://dx.doi.org/10.1016/j.chest.2022.08.1938 Text en Copyright © 2022 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Pulmonary Vascular Disease
KELTY, CATHERINE
LEACCHE, MARZIA
KNOX, MICHAEL
H PITCHER, JOSEPH
BERJAOUI, WAEL
M VANOTTEREN, GLENN
CUMMINGS, TREVOR
SHRESTHA, NABIN
L VANDYKE, ERIN
J MORRISON, JAMES
LOYAGA-RENDON, RENZO
DIFFERENCES IN CLINICAL CHARACTERISTICS, TREATMENT, AND OUTCOME OF PULMONARY EMBOLISM ACCORDING TO COVID-19 STATUS
title DIFFERENCES IN CLINICAL CHARACTERISTICS, TREATMENT, AND OUTCOME OF PULMONARY EMBOLISM ACCORDING TO COVID-19 STATUS
title_full DIFFERENCES IN CLINICAL CHARACTERISTICS, TREATMENT, AND OUTCOME OF PULMONARY EMBOLISM ACCORDING TO COVID-19 STATUS
title_fullStr DIFFERENCES IN CLINICAL CHARACTERISTICS, TREATMENT, AND OUTCOME OF PULMONARY EMBOLISM ACCORDING TO COVID-19 STATUS
title_full_unstemmed DIFFERENCES IN CLINICAL CHARACTERISTICS, TREATMENT, AND OUTCOME OF PULMONARY EMBOLISM ACCORDING TO COVID-19 STATUS
title_short DIFFERENCES IN CLINICAL CHARACTERISTICS, TREATMENT, AND OUTCOME OF PULMONARY EMBOLISM ACCORDING TO COVID-19 STATUS
title_sort differences in clinical characteristics, treatment, and outcome of pulmonary embolism according to covid-19 status
topic Pulmonary Vascular Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548725/
http://dx.doi.org/10.1016/j.chest.2022.08.1938
work_keys_str_mv AT keltycatherine differencesinclinicalcharacteristicstreatmentandoutcomeofpulmonaryembolismaccordingtocovid19status
AT leacchemarzia differencesinclinicalcharacteristicstreatmentandoutcomeofpulmonaryembolismaccordingtocovid19status
AT knoxmichael differencesinclinicalcharacteristicstreatmentandoutcomeofpulmonaryembolismaccordingtocovid19status
AT hpitcherjoseph differencesinclinicalcharacteristicstreatmentandoutcomeofpulmonaryembolismaccordingtocovid19status
AT berjaouiwael differencesinclinicalcharacteristicstreatmentandoutcomeofpulmonaryembolismaccordingtocovid19status
AT mvanotterenglenn differencesinclinicalcharacteristicstreatmentandoutcomeofpulmonaryembolismaccordingtocovid19status
AT cummingstrevor differencesinclinicalcharacteristicstreatmentandoutcomeofpulmonaryembolismaccordingtocovid19status
AT shresthanabin differencesinclinicalcharacteristicstreatmentandoutcomeofpulmonaryembolismaccordingtocovid19status
AT lvandykeerin differencesinclinicalcharacteristicstreatmentandoutcomeofpulmonaryembolismaccordingtocovid19status
AT jmorrisonjames differencesinclinicalcharacteristicstreatmentandoutcomeofpulmonaryembolismaccordingtocovid19status
AT loyagarendonrenzo differencesinclinicalcharacteristicstreatmentandoutcomeofpulmonaryembolismaccordingtocovid19status